Blue Note Therapeutics to Present Health Economic Data at
SAN FRANCISCO, March 24, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics today announced that new data from a health economic study of anxiety and...
Stay updated with breaking news from Note Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN FRANCISCO, March 24, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics today announced that new data from a health economic study of anxiety and...
/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Blue Note Therapeutics, a prescription digital therapeutics...
/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Blue Note Therapeutics, a prescription digital therapeutics...
SAN FRANCISCO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics, a prescription digital therapeutics company dedicated to easing the burden of...
Share Cedar, the maker of an intelligent patient billing and engagement platform, announced today a $200 million Series D round of funding headed by Tiger Global Management, with participation from prior backers including Andreessen Horowitz (a16z), Thrive Capital and Concord Health Partners. This brings the company's total fundraising haul to $350 million, it said, and its valuation to $3.2 billion. Cedar said that its patient-friendly digital offering has helped quadruple its business throughout the course of 2020 and now engages with more than 300,000 patients per day. It said it will...